Matches in Ghent University Academic Bibliography for { <https://biblio.ugent.be/publication/01GJMD4CGVG6ATHV9WC2X3TMZD> ?p ?o. }
Showing items 1 to 23 of
23
with 100 items per page.
- 01GJMD4CGVG6ATHV9WC2X3TMZD classification D1.
- 01GJMD4CGVG6ATHV9WC2X3TMZD promoter 09B8950E-F0EE-11E1-A9DE-61C894A0A6B4.
- 01GJMD4CGVG6ATHV9WC2X3TMZD promoter F4C47320-F0ED-11E1-A9DE-61C894A0A6B4.
- 01GJMD4CGVG6ATHV9WC2X3TMZD promoter F4E63960-F0ED-11E1-A9DE-61C894A0A6B4.
- 01GJMD4CGVG6ATHV9WC2X3TMZD promoter F578A96C-F0ED-11E1-A9DE-61C894A0A6B4.
- 01GJMD4CGVG6ATHV9WC2X3TMZD date "2022".
- 01GJMD4CGVG6ATHV9WC2X3TMZD language "eng".
- 01GJMD4CGVG6ATHV9WC2X3TMZD type dissertation.
- 01GJMD4CGVG6ATHV9WC2X3TMZD hasPart urn:uuid:5cf84276-bc28-42cd-9dec-667ceb2b5493.
- 01GJMD4CGVG6ATHV9WC2X3TMZD hasPart urn:uuid:c2666404-874e-48ff-a9a0-9b0ff531f8bf.
- 01GJMD4CGVG6ATHV9WC2X3TMZD subject "Veterinary Sciences".
- 01GJMD4CGVG6ATHV9WC2X3TMZD abstract "Tendon and ligament injuries are a very common problem in equine athletes, and often result in reinjury due to scar tissue repair resulting in early retirement from an athletic career or pleasure riding. The formation of scar tissue of inferior quality cannot be overcome by the current advanced therapies. Recently, promising advances have been made in the field of biological therapies by treating equine tendon injuries with mesenchymal stem cells (MSCs). Although MSCs are a valuable option in the treatment of tendon disease, their tenogenic properties and regenerative effects could be compromised by the inflammatory environment of the acute tendon injury. To avoid these disadvantageous effects, mesenchymal stem cells can be tenogenic primed before clinical application. Nevertheless, the mechanism of action and functional properties of the tenogenic primed MSCs are still not fully understood. Therefore, the overarching aim of this PhD thesis was to investigate equine allogeneic peripheral blood-derived tenogenic primed mesenchymal stem cells (tpMSCs) as a treatment for tendon and ligament injuries in horses.".
- 01GJMD4CGVG6ATHV9WC2X3TMZD author 05CE3F7E-F0EF-11E1-A197-91C894A0A6B4.
- 01GJMD4CGVG6ATHV9WC2X3TMZD dateCreated "2022-11-24T08:47:38Z".
- 01GJMD4CGVG6ATHV9WC2X3TMZD dateModified "2024-10-29T08:51:35Z".
- 01GJMD4CGVG6ATHV9WC2X3TMZD name "The potential of equine tenogenic primed mesenchymal stem cells for horses with tendon injuries".
- 01GJMD4CGVG6ATHV9WC2X3TMZD pagination urn:uuid:f4fd279a-1f03-4072-be3d-dbf2834cc4cd.
- 01GJMD4CGVG6ATHV9WC2X3TMZD publisher urn:uuid:ee5e86ab-f49a-450a-be48-8b5b4eb959a0.
- 01GJMD4CGVG6ATHV9WC2X3TMZD sameAs LU-01GJMD4CGVG6ATHV9WC2X3TMZD.
- 01GJMD4CGVG6ATHV9WC2X3TMZD sourceOrganization urn:uuid:4fd4642f-ee48-4746-89ca-083a7c819023.
- 01GJMD4CGVG6ATHV9WC2X3TMZD sourceOrganization urn:uuid:60c05d2c-3e85-47ba-92b6-2122632fe9e8.
- 01GJMD4CGVG6ATHV9WC2X3TMZD sourceOrganization urn:uuid:8bb15410-3fb6-4ed4-95bf-e14c1c970866.
- 01GJMD4CGVG6ATHV9WC2X3TMZD type D1.